Antonela Fuselli

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 9

Top Topics

Respiratory Syndrome Coronavirus

Angiotensin Converting Enzyme

Protein Protein

Top Venues

Applied microbiology and biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Ernesto Garay, María Celeste Rodríguez, Diego Fontana, Sebastián Antuña, Victoria Gastaldi, Juan Manuel Battagliotti, María Belén Tardivo, Diego E Álvarez, Eliana F Castro, Juliana Cassataro, Natalia Ceaglio, Claudio C Prieto
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied microbiology and biotechnology (2023)
Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Ernesto Garay, María Celeste Rodríguez, Diego Fontana, Sebastián Antuña, Victoria Gastaldi, Juan Manuel Battagliotti, María Belén Tardivo, Diego E Álvarez, Eliana F Castro, Juliana Cassataro, Natalia Ceaglio, Claudio C Prieto
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied microbiology and biotechnology 107 (11) (2023)
Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Ernesto Garay, María Celeste Rodríguez, Diego Fontana, Sebastián Antuña, Victoria Gastaldi, Juan Manuel Battagliotti, María Belén Tardivo, Diego E Álvarez, Eliana F Castro, Juliana Cassataro, Natalia Ceaglio, Claudio C Prieto
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied microbiology and biotechnology (2023)
Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Ernesto Garay, María Celeste Rodríguez, Diego Fontana, Sebastián Antuña, Victoria Gastaldi, Juan Manuel Battagliotti, María Belén Tardivo, Diego E Álvarez, Eliana F Castro, Juliana Cassataro, Natalia Ceaglio, Claudio C Prieto
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied microbiology and biotechnology 107 (11) (2023)
Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Ernesto Garay, María Celeste Rodríguez, Diego Fontana, Sebastián Antuña, Victoria Gastaldi, Juan Manuel Battagliotti, María Belén Tardivo, Diego E Álvarez, Eliana F Castro, Juliana Cassataro, Natalia Ceaglio, Claudio C Prieto
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied microbiology and biotechnology 107 (11) (2023)
Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Ernesto Garay, María Celeste Rodríguez, Diego Fontana, Sebastián Antuña, Victoria Gastaldi, Juan Manuel Battagliotti, María Belén Tardivo, Diego E Álvarez, Eliana F Castro, Juliana Cassataro, Natalia Ceaglio, Claudio C Prieto
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied microbiology and biotechnology (2023)
Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Ernesto Garay, María Celeste Rodríguez, Diego Fontana, Sebastián Antuña, Victoria Gastaldi, Juan Manuel Battagliotti, María Belén Tardivo, Diego E Álvarez, Eliana F Castro, Juliana Cassataro, Natalia Ceaglio, Claudio C Prieto
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied microbiology and biotechnology (2023)
María Celeste Rodríguez, Natalia Ceaglio, Agustina Gugliotta, Javier Villarraza, Ernesto Garay, Antonela Fuselli, Victoria Gastaldi, María Belén Tardivo, Sebastián Antuña, Diego Fontana, Claudio C Prieto
Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 protein. Applied microbiology and biotechnology 106 (23) (2022)
Antonela Fuselli, María de Los Milagros Bürgi, Ricardo B Kratje, Claudio C Prieto
Generation and functional evaluation of novel monoclonal antibodies targeting glycosylated human stem cell factor. Applied microbiology and biotechnology 106 (24) (2022)